Annual Report

Overview

The report presents Mabpharm and its subsidiaries' 2021 ESG performance, including Scope 1 and Scope 2 greenhouse gas emissions of 8,104.02 tons, energy consumption of 13,722.95 (1,000 KWh), water consumption of 155,132.10 m3 and a workforce of 484 employees. It also describes Board-led ESG governance, a materiality matrix and a TCFD-referenced climate-risk assessment. The report records zero work-related fatalities during the period.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2021
Period: 1 January 2021 – 31 December 2021
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services